1.
|
Octreotid Labatec
|
Inj Lös 0.05 mg/ml
|
5 Amp 1 ml
|
19.99
|
38.15
|
01.12.2023
|
|
|
L
|
Nein
|
63241001
|
Labatec Pharma SA
|
Octreotidum
|
20254
|
01.07.2014
|
|
|
|
G
|
07.16.20.
|
H01CB02
|
2.
|
Octreotid Labatec
|
Inj Lös 0.1 mg/ml
|
5 Amp 1 ml
|
37.24
|
56.90
|
01.12.2023
|
|
|
L
|
Nein
|
63241002
|
Labatec Pharma SA
|
Octreotidum
|
20254
|
01.07.2014
|
|
|
|
G
|
07.16.20.
|
H01CB02
|
3.
|
Octreotid Labatec
|
Inj Lös 0.5 mg/ml
|
5 Amp 1 ml
|
204.98
|
239.35
|
01.12.2023
|
|
|
L
|
Nein
|
63241003
|
Labatec Pharma SA
|
Octreotidum
|
20254
|
01.07.2014
|
|
|
|
G
|
07.16.20.
|
H01CB02
|
4.
|
Octreotid Labatec
|
Inj Lös 1 mg/5ml
|
Durchstf 5 ml
|
69.54
|
92.05
|
01.12.2023
|
|
|
L
|
Nein
|
65110001
|
Labatec Pharma SA
|
Octreotidum
|
20254
|
01.07.2014
|
|
|
|
G
|
07.16.20.
|
H01CB02
|
5.
|
Sandostatin
|
Inj Lös 0.05 mg/ml
|
5 Amp 1 ml
|
22.19
|
40.40
|
01.12.2023
|
|
|
L
|
Nein
|
49137028
|
Novartis Pharma Schweiz AG
|
Octreotidum
|
15538
|
15.03.1989
|
|
|
|
O
|
07.16.20.
|
H01CB02
|
6.
|
Sandostatin
|
Inj Lös 0.1 mg/ml
|
5 Amp 1 ml
|
41.38
|
61.15
|
01.12.2023
|
|
|
L
|
Nein
|
49137044
|
Novartis Pharma Schweiz AG
|
Octreotidum
|
15538
|
15.03.1989
|
|
|
|
O
|
07.16.20.
|
H01CB02
|
7.
|
Sandostatin
|
Inj Lös 0.5 mg/ml
|
5 Amp 1 ml
|
227.65
|
262.60
|
01.12.2023
|
|
|
L
|
Nein
|
49137079
|
Novartis Pharma Schweiz AG
|
Octreotidum
|
15538
|
15.03.1997
|
|
|
|
O
|
07.16.20.
|
H01CB02
|
8.
|
Sandostatin LAR
|
Trockensub 10 mg c Sol
|
1 Stk
|
505.79
|
560.55
|
01.12.2023
|
|
|
L
|
Nein
|
53161004
|
Novartis Pharma Schweiz AG
|
Octreotidum
|
16484
|
15.03.1997
|
|
|
|
O
|
07.16.20.
|
H01CB02
|
9.
|
Sandostatin LAR
|
Trockensub 20 mg c Sol
|
1 Stk
|
897.90
|
982.40
|
01.12.2023
|
|
|
L
|
Nein
|
53161005
|
Novartis Pharma Schweiz AG
|
Octreotidum
|
16484
|
15.03.1997
|
|
|
|
O
|
07.16.20.
|
H01CB02
|
10.
|
Sandostatin LAR
|
Trockensub 30 mg c Sol
|
1 Stk
|
1265.46
|
1377.85
|
01.12.2023
|
|
|
L
|
Nein
|
53161006
|
Novartis Pharma Schweiz AG
|
Octreotidum
|
16484
|
15.03.1997
|
|
|
|
O
|
07.16.20.
|
H01CB02
|